{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06152237",
            "orgStudyIdInfo": {
                "id": "TSHA-102-CL-102"
            },
            "organization": {
                "fullName": "Taysha Gene Therapies, Inc.",
                "class": "INDUSTRY"
            },
            "briefTitle": "Safety and Efficacy of TSHA-102 in Pediatric Females With Rett Syndrome (REVEAL Pediatric Study)",
            "officialTitle": "A Multicenter, Open Label, Randomized, Dose-Escalation and Dose-Expansion Study of the Safety, Tolerability, and Efficacy of a Single Intrathecal Administration of TSHA-102, an AAV9-Delivered Gene Therapy, for the Treatment of Pediatric Females With Rett Syndrome",
            "therapeuticArea": [
                "Rare Diseases"
            ],
            "study": "safety-and-efficacy-of-tsha-in-pediatric-females-with-rett-syndrome-reveal-pediatric-study"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-07",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2023-12-12",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2028-11-02",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2031-11-02",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2023-11-21",
            "studyFirstSubmitQcDate": "2023-11-21",
            "studyFirstPostDateStruct": {
                "date": "2023-11-30",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-07-26",
            "lastUpdatePostDateStruct": {
                "date": "2024-07-30",
                "type": "ESTIMATED"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Taysha Gene Therapies, Inc.",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false,
            "isUsExport": true
        },
        "descriptionModule": {
            "briefSummary": "The REVEAL Pediatric Study is a multi-center, Phase 1/2 open-label, dose-escalation and dose-expansion study of TSHA-102, an investigational gene therapy, in pediatric females with Rett Syndrome.\n\nThe safety, tolerability, and preliminary efficacy of two dose levels will be evaluated. The study duration is up to 6 years."
        },
        "conditionsModule": {
            "conditions": [
                "Rett Syndrome"
            ],
            "keywords": [
                "Rett Syndrome",
                "Neurodevelopmental Disorder",
                "MECP2"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE1"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "SEQUENTIAL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 6,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Cohort 1",
                    "type": "EXPERIMENTAL",
                    "description": "Dose Level 1",
                    "interventionNames": [
                        "Genetic: TSHA-102"
                    ]
                },
                {
                    "label": "Cohort 2",
                    "type": "EXPERIMENTAL",
                    "description": "Dose Level 2",
                    "interventionNames": [
                        "Genetic: TSHA-102"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "GENETIC",
                    "name": "TSHA-102",
                    "description": "TSHA-102 is a recombinant, non-replicating, self-complementary AAV9 (scAAV9) vector encoding for the miniMECP2 gene. TSHA-102 is a one-time intrathecal (IT) administration.",
                    "armGroupLabels": [
                        "Cohort 1",
                        "Cohort 2"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Primary Safety",
                    "description": "The incidence of participants experiencing any treatment-emergent adverse events (AEs) and serious adverse events (SAEs)",
                    "timeFrame": "Baseline through week 52"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Exploratory Efficacy",
                    "description": "Change from baseline in participant's status after TSHA-102 administration as assessed by Clinical Global Impressions Improvement (CGI-I). This 7-point scale (1 = very much improved, 7 = very much worse, etc.) is used by the clinician to assess the participant's overall performance status; higher scores indicate increased severity.",
                    "timeFrame": "Baseline through week 52"
                },
                {
                    "measure": "Exploratory Efficacy",
                    "description": "Change from baseline in participant's status after TSHA-102 administration as assessed by Revised Motor Behavior Assessment (R-MBA). This 34-item questionnaire with scores of 0-4 will be administered by a cliniciant to indicate frequency of daily activities (behavioral/social, respiratory, motor/physical, etc.) in participants with Rett Syndrome. Higher scores correlate with greater clinical severity of disease.",
                    "timeFrame": "Baseline through week 52"
                },
                {
                    "measure": "Exploratory Efficacy",
                    "description": "Change from baseline in participant's status after TSHA-102 administration as assessed by Rett Syndrome Behavior Questionnaire (RSBQ). The RSBQ is a 45-item questionnaire and is completed by the participant's Caregiver. Scores (0 = not true, 1 = somewhat/sometimes true, or 2 = very true) are applied to subscales including General Mood, Breathing Problems, Fear/Anxiety, Walking/Standing, etc.; higher scores indicate greater severity.",
                    "timeFrame": "Baseline through week 52"
                },
                {
                    "measure": "Exploratory Efficacy",
                    "description": "Change from baseline in participant's status after TSHA-102 administration as assessed by Clinical Global Impressions-Severity (CGI-S). This 7-point scale (1 = normal - not I'll all all, 7 = extremely ill, etc.) will be administered by a clinician, based on their experience with patients with the same diagnosis. A higher score indicates greater severity of illness.",
                    "timeFrame": "Baseline through week 52"
                },
                {
                    "measure": "Exploratory Efficacy",
                    "description": "Change from baseline in quantitative EEG findings with auditory evoked potential and visual evoked potentials (AEP and VEP). This testing will provide a measure of the electrophysiologic responses of the brain to visual and auditory stimuli.",
                    "timeFrame": "Baseline through week 52"
                },
                {
                    "measure": "Exploratory Efficacy",
                    "description": "The percent change from the steroid-free baseline period in monthly countable seizure frequency (MCSF). This testing will provide a measure of participants with seizure freedom following administration of TSHA-102.",
                    "timeFrame": "Baseline through week 52"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Participant has a confirmed diagnosis of classical/typical Rett Syndrome with a documented mutation of the MECP2 gene that results in loss of function.\n* Participant is between \u22655 to \u22648 years of age at the time of consent.\n* Participant must be up to date with all relevant local vaccination requirements, with last vaccination dose received at least 42 days prior to the start of the immunosuppression regimen.\n* Participant's parent/caregiver must be willing to allow participant to receive blood or blood products for the treatment of an AE if medically needed.\n\nExclusion Criteria:\n\n* Participant has another neurodevelopmental disorder independent of the MECP2 gene loss of function mutation, or any other genetic syndrome with a progressive course.\n* Participant has a history of brain injury that causes neurological problems.\n* Participant had grossly abnormal psychomotor development in the first 6 months of life.\n* Participant has a diagnosis of atypical Rett syndrome.\n* Participant has an MECP2 mutation that does not cause Rett syndrome.\n* Participant requires non-invasive and invasive ventilatory support.\n* Participant has contraindications for IT administration of TSHA-102 or lumbar puncture procedure, other medical conditions, or contraindications to any medications required for IT administration.\n* Participant has acute or chronic hepatitis B or C infections.",
            "healthyVolunteers": false,
            "sex": "FEMALE",
            "minimumAge": "5 Years",
            "maximumAge": "8 Years",
            "stdAges": [
                "CHILD"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Taysha Gene Therapies Medical Information",
                    "role": "CONTACT",
                    "phone": "1-833-489-8742",
                    "email": "medinfo@tayshagtx.com"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Meredith Schultz, M.D.",
                    "affiliation": "Taysha Gene Therapies",
                    "role": "STUDY_DIRECTOR"
                }
            ],
            "locations": [
                {
                    "facility": "University of California San Diego (UCSD)",
                    "status": "NOT_YET_RECRUITING",
                    "city": "La Jolla",
                    "state": "California",
                    "zip": "92037",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 32.84727,
                        "lon": -117.2742
                    }
                },
                {
                    "facility": "Rush University Medical Center",
                    "status": "RECRUITING",
                    "city": "Chicago",
                    "state": "Illinois",
                    "zip": "60612",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Milana Milic",
                            "role": "CONTACT",
                            "phone": "312-942-4670",
                            "email": "milana_milic@rush.edu"
                        },
                        {
                            "name": "Samantha Dreyer",
                            "role": "CONTACT",
                            "phone": "312-563-9304",
                            "email": "samantha_l_dreyer@rush.edu"
                        },
                        {
                            "name": "Elizabeth Berry-Kravis, MD, PhD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 41.85003,
                        "lon": -87.65005
                    }
                },
                {
                    "facility": "Boston Children's at Brookline",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Boston",
                    "state": "Massachusetts",
                    "zip": "02445",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Grace Correa",
                            "role": "CONTACT",
                            "phone": "617-355-5230",
                            "email": "rettresearch@childrens.harvard.edu"
                        },
                        {
                            "name": "David Lieberman, MD, PhD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 42.35843,
                        "lon": -71.05977
                    }
                },
                {
                    "facility": "Gillette Children's Specialty Healthcare",
                    "status": "RECRUITING",
                    "city": "Saint Paul",
                    "state": "Minnesota",
                    "zip": "55101",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Emily Hince, CCRC",
                            "role": "CONTACT",
                            "phone": "651-229-3961",
                            "email": "emilyahince@gillettechildrens.com"
                        },
                        {
                            "name": "Timothy Feyma, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 44.94441,
                        "lon": -93.09327
                    }
                },
                {
                    "facility": "Washington University, St. Louis",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Saint Louis",
                    "state": "Missouri",
                    "zip": "63110",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Ali Vonderheid",
                            "role": "CONTACT",
                            "email": "neuro_rettresearch@email.wustl.edu"
                        },
                        {
                            "name": "Robin Ryther, MD, PhD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 38.62727,
                        "lon": -90.19789
                    }
                },
                {
                    "facility": "Children's Hospital of Philadelphia Research Institute",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Philadelphia",
                    "state": "Pennsylvania",
                    "zip": "19104",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Jennie Minnick",
                            "role": "CONTACT",
                            "phone": "267-426-1242",
                            "email": "minnick@chop.edu"
                        },
                        {
                            "name": "Eric Marsh, MD, PhD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.95233,
                        "lon": -75.16379
                    }
                },
                {
                    "facility": "Vanderbilt Kennedy Center",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Nashville",
                    "state": "Tennessee",
                    "zip": "37203",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Madeline Rockouski",
                            "role": "CONTACT",
                            "phone": "615-322-1140",
                            "email": "madeline.a.rockouski@vumc.org"
                        },
                        {
                            "name": "Jeffrey Neul, MD, PhD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 36.16589,
                        "lon": -86.78444
                    }
                },
                {
                    "facility": "University of Texas Southwestern Medical Center (UTSW)",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Dallas",
                    "state": "Texas",
                    "zip": "75390",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 32.78306,
                        "lon": -96.80667
                    }
                },
                {
                    "facility": "CHU Ste-Justine",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Montr\u00e9al",
                    "state": "Quebec",
                    "zip": "H3T 1C5",
                    "country": "Canada",
                    "contacts": [
                        {
                            "name": "Caroline Jouy",
                            "role": "CONTACT",
                            "phone": "514-345-4931",
                            "phoneExt": "6788",
                            "email": "caroline.amiot.jouy.hsj@ssss.gouv.qc.ca"
                        },
                        {
                            "name": "Elsa Rossignol, M.D., M.Sc.",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 45.50884,
                        "lon": -73.58781
                    }
                },
                {
                    "facility": "Children's Neurosciences, Evelina London Children's Hospital, Guy's and St Thomas' NHS Foundation Trust",
                    "status": "NOT_YET_RECRUITING",
                    "city": "London",
                    "country": "United Kingdom",
                    "contacts": [
                        {
                            "name": "Lumsden",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 51.50853,
                        "lon": -0.12574
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000015518",
                    "term": "Rett Syndrome"
                },
                {
                    "id": "D000013577",
                    "term": "Syndrome"
                }
            ],
            "ancestors": [
                {
                    "id": "D000004194",
                    "term": "Disease"
                },
                {
                    "id": "D000010335",
                    "term": "Pathologic Processes"
                },
                {
                    "id": "D000038901",
                    "term": "Mental Retardation, X-Linked"
                },
                {
                    "id": "D000008607",
                    "term": "Intellectual Disability"
                },
                {
                    "id": "D000019954",
                    "term": "Neurobehavioral Manifestations"
                },
                {
                    "id": "D000009461",
                    "term": "Neurologic Manifestations"
                },
                {
                    "id": "D000009422",
                    "term": "Nervous System Diseases"
                },
                {
                    "id": "D000040181",
                    "term": "Genetic Diseases, X-Linked"
                },
                {
                    "id": "D000030342",
                    "term": "Genetic Diseases, Inborn"
                },
                {
                    "id": "D000020271",
                    "term": "Heredodegenerative Disorders, Nervous System"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M16355",
                    "name": "Syndrome",
                    "asFound": "Syndrome",
                    "relevance": "HIGH"
                },
                {
                    "id": "M30644",
                    "name": "Neurodevelopmental Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M18163",
                    "name": "Rett Syndrome",
                    "asFound": "Rett Syndrome",
                    "relevance": "HIGH"
                },
                {
                    "id": "M11589",
                    "name": "Intellectual Disability",
                    "relevance": "LOW"
                },
                {
                    "id": "M24774",
                    "name": "Mental Retardation, X-Linked",
                    "relevance": "LOW"
                },
                {
                    "id": "M21826",
                    "name": "Neurobehavioral Manifestations",
                    "relevance": "LOW"
                },
                {
                    "id": "M12404",
                    "name": "Neurologic Manifestations",
                    "relevance": "LOW"
                },
                {
                    "id": "M24877",
                    "name": "Genetic Diseases, X-Linked",
                    "relevance": "LOW"
                },
                {
                    "id": "M23686",
                    "name": "Genetic Diseases, Inborn",
                    "relevance": "LOW"
                },
                {
                    "id": "M22092",
                    "name": "Heredodegenerative Disorders, Nervous System",
                    "relevance": "LOW"
                },
                {
                    "id": "T4987",
                    "name": "Rett Syndrome",
                    "asFound": "Rett Syndrome",
                    "relevance": "HIGH"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BXM",
                    "name": "Behaviors and Mental Disorders"
                },
                {
                    "abbrev": "BC10",
                    "name": "Nervous System Diseases"
                },
                {
                    "abbrev": "BC16",
                    "name": "Diseases and Abnormalities at or Before Birth"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        }
    },
    "hasResults": false
}